The tyrosine kinase Lck is a positive regulator of the mitochondrial apoptosis pathway by controlling Bak expression

A K Samraj1, C Stroh, U Fischer

  • 1Institute of Molecular Medicine, University of Düsseldorf, Germany.

Oncogene
|August 24, 2005
PubMed

Insights

The lymphoid-specific Src kinase p56(Lck) regulates mitochondrial apoptosis. Lck deficiency confers drug resistance by blocking Bak expression, while Lck re-expression restores sensitivity via Bak activation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • Src family kinases (SFKs) are crucial in cellular signaling.
  • p56(Lck) is a lymphoid-specific SFK involved in T-cell function.
  • The role of Lck in apoptosis, particularly the mitochondrial pathway, is not fully understood.

Purpose of the Study:

  • To investigate the role of p56(Lck) in drug-induced apoptosis.
  • To elucidate the specific pathway through which Lck influences apoptosis.
  • To identify downstream targets of Lck in the apoptotic process.

Main Methods:

  • Utilized Lck-deficient T cells and Lck-reconstituted cells.
  • Assessed sensitivity to anticancer drugs and death receptor-mediated apoptosis.
  • Analyzed mitochondrial cytochrome c release, caspase activation, and Bcl-2 protein expression (Bak).
  • Investigated the transcriptional regulation of Bak by Lck.
  • Performed in vitro assays using truncated Bid to assess Bak activation.

Main Results:

  • Lck-deficient T cells exhibited complete resistance to anticancer drugs but normal sensitivity to death receptors.
  • Re-expression of Lck restored drug sensitivity, triggering cytochrome c release and caspase activation.
  • Lck-mediated sensitization was independent of classical T-cell signaling but critically involved Bak.
  • Lck deficiency resulted in absent Bak expression; Lck re-expression induced Bak transcription and activation.
  • Lck-expressing cells showed enhanced Bak-mediated cytochrome c release upon Bid activation.

Conclusions:

  • p56(Lck) plays a critical role in regulating the mitochondrial apoptosis pathway, specifically in response to anticancer drugs.
  • Lck acts as a sentinel in drug resistance by transcriptionally inducing the expression and activation of the proapoptotic protein Bak.
  • This study reveals a novel pathway for Src kinases in regulating Bcl-2 family proteins and offers potential therapeutic targets for overcoming drug resistance.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.